Structure

InChI Key VHBFFQKBGNRLFZ-UHFFFAOYSA-N
Smiles O=c1cc(-c2ccccc2)oc2ccccc12
InChI
InChI=1S/C15H10O2/c16-13-10-15(11-6-2-1-3-7-11)17-14-9-5-4-8-12(13)14/h1-10H

Physicochemical Descriptors

Property Name Value
Molecular Formula C15H10O2
Molecular Weight 222.24
AlogP 3.46
Hydrogen Bond Acceptor 2.0
Hydrogen Bond Donor 0.0
Number of Rotational Bond 1.0
Polar Surface Area 30.21
Molecular species NEUTRAL
Aromatic Rings 3.0
Heavy Atoms 17.0
Assay Description Organism Bioactivity Reference
Compound was evaluated for inhibition constant, in liver microsomes from 3-methylcholanthrene-exposed rats Rattus norvegicus 33.0 nM
Compound was evaluated for inhibition constant, in liver microsomes from beta-naphthoflavone-exposed rats Rattus norvegicus 190.0 nM
In vitro inhibition of aminopeptidase N (APN) activity in intact U937 cells in presence of Ala-pNA and 10e-3 M concentration of compound None 5.0 %
Inhibition of binding to GABA-A Benzodiazepine receptor None 17.0 nM
Evaluated for inhibition of COX-2 catalyzed PGE-2 production from LPS induced RAW 264.7 cells Mus musculus 500.0 nM
Inhibition of COX-2 catalyzed PGE-2 production from LPS induced RAW 264.7 cells at concentration of 10 uM None 92.2 %
Inhibition of beef heart mitochondrial NADH oxidase assessed per mg of protein Bos taurus 240.0 nM
Inhibition of cow milk xanthine oxidase at 50 ug/mL Bos taurus 15.4 %
Pesticidal activity against Dermatophagoides pteronyssinus after 24 hrs Dermatophagoides pteronyssinus 0.5 g/m2
Inhibition of EGFR in human A431 cells Homo sapiens 50.0 ug.mL-1
Antimalarial activity against Plasmodium falciparum DD2 by [3H]hypoxanthine uptake Plasmodium falciparum 2.0 nM
Inhibition of PDE4 in human U937 cells assessed as inhibition of cAMP hydrolysis at 11 uM by SPA Homo sapiens 50.0 %
Inhibition of human recombinant MAOA expressed in BTI-TN-5B1-4 cells at 100 uM by para-tyramine oxidation assay Homo sapiens 40.0 %
Inhibition of human placental microsome CYP19 Homo sapiens 8.0 nM
Inhibition of human 11beta HSD1 in HEK293 cells at 10 uM Homo sapiens 16.0 %
Inhibition of Trypanosoma cruzi triosephosphate isomerase at 100 uM after 2 hrs Trypanosoma cruzi 52.0 %
Inhibition of Trypanosoma cruzi triosephosphate isomerase at 400 uM after 2 hrs Trypanosoma cruzi 83.0 %
Inhibition of NF-kappaB activation expressed in HCT116 cells assessed as inhibition of TNF-alpha-induced transcriptional activation at 10 uM after 12 hrs by luciferase reporter gene assay relative to control None 113.49 %
Antioxidant activity assessed as inhibition of DPPH radical production at 33 uM after 5 min by spectrophotometric analysis None 1.5 %
Antioxidant activity in Wistar albino Rattus norvegicus (rat) liver microsomes assessed as inhibition of lipid peroxidation after 1 hr by TBARS method Rattus norvegicus 100.0 ug.mL-1
Inhibition of human 6XHis-tagged TNKS2 ART domain (946 to 1161 amino acid residues) expressed in Escherichia coli Rosetta2 (DE3) by fluorescence assay Homo sapiens 147.91 nM Inhibition of human 6XHis-tagged TNKS2 ART domain (946 to 1161 amino acid residues) expressed in Escherichia coli Rosetta2 (DE3) by fluorescence assay Homo sapiens 140.0 nM
Inhibition of human 6XHis-tagged TNKS1 SAM-ART domain (1030 to 1317 amino acid residues) by fluorescence assay Homo sapiens 323.59 nM Inhibition of human 6XHis-tagged TNKS1 SAM-ART domain (1030 to 1317 amino acid residues) by fluorescence assay Homo sapiens 320.0 nM
Inhibition of oxidative burst in PMA-stimulated human neutrophils assessed as inhibition of ROS-induced luminol oxidation up to 100 uM incubated for 5 mins prior to PMA challenge by chemiluminescence assay Homo sapiens 40.0 %
Inhibition of human TNKS1 (1030 to 1317) using NAD+ as substrate by fluorescence assay Homo sapiens 323.59 nM Inhibition of human TNKS1 (1030 to 1317) using NAD+ as substrate by fluorescence assay Homo sapiens 330.0 nM
Inhibition of 5-LOX-mediated LTB4 production in human neutrophils using arachidonic acid as substrate at 40 uM preincubated for 10 mins followed by substrate addition measured after 8 mins by enzyme immunoassay relative to control Homo sapiens 50.0 %
Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins None 100.0 ug.mL-1
Inhibition of PMA-induced oxidative burst in human neutrophils at 50 uM by chemiluminescence assay Homo sapiens 40.0 %
Inhibition of PMA-induced oxidative burst in human neutrophils at 50 uM by amplex red assay Homo sapiens 40.0 %
Inhibition of PMA-induced oxidative burst in human neutrophils at 50 uM by APF assay Homo sapiens 40.0 %
Inhibition of sucrose loaded POPC/POPE/POPS/PtdIns(3,4,5)P3 (59:20:20:1) liposome binding to eGFP-fused PDK1 PH domain (unknown origin) expressed in Escherichia coli BL21 at 20 uM after 10 mins by fluorescence spectrophotometry based pull down assay relative to control Homo sapiens -1.93 %
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-stimulated NO production at 20 uM by ELISA relative to control Mus musculus 16.33 %
Inhibition of human CYP1B1 expressed in Escherichia coli DH5alpha coexpressing human NADPH P450 reductase using 7-ethoxyresorufin as substrate in presence of NADP+ by spectrofluorometeric analysis Homo sapiens 600.0 nM
Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate preincubated for 4 secs followed by substrate addition and measured after 30 mins by luminescence assay Homo sapiens 170.0 nM
Inhibition of human liver FBP1 at 200 uM incubated for 5 mins by fluorescence method relative to control Homo sapiens 20.0 %
Inhibition of cytochrome c (unknown origin) assessed as reduction in cyt c-CL complex formation at 10 uM incubated for 15 mins in presence of cardiolipin by Trp-59 fluorescence assay relative to control Homo sapiens 87.0 %
Inhibition of cytochrome c (unknown origin) assessed as reduction in cyt c-CL peroxidase activity at 10 uM up to 20 mins in presence of cardiolipin by Amplex red staining based fluorescence assay relative to control Homo sapiens 50.0 %
Inhibition of cytochrome c (unknown origin) assessed as reduction reduction of cyt c from its ferric state to ferrous state at 10 uM incubated for 20 mins in presence of cardiolipin by UV-vis Spectrophotometric assay relative to control Homo sapiens 0.0 %

Related Entries

Cross References

Resources Reference
ChEBI 42491
ChEMBL CHEMBL275638
DrugBank DB07776
FDA SRS S2V45N7G3B
Human Metabolome Database HMDB0003075
Guide to Pharmacology 409
KEGG C15608
PDB FLN
PubChem 10680
SureChEMBL SCHEMBL18879
ZINC ZINC000000057674